Pathogenic and Protective T cells in Toxoplasmosis
Pathogenic and Protective T cells in Toxoplasmosis
批准号:
8718994
负责人:
George S. Yap
金额:
$39.35万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-01 至 2016-06-30
关键词:
AnimalsAnti-Inflammatory AgentsAnti-inflammatoryAntigen-Presenting CellsAntigensAutomobile DrivingCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCD8B1 geneCell LineageCellsCollaborationsCommunicable DiseasesCosts and BenefitsCytokine SignalingDiseaseEpitopesEquilibriumFeedbackGenerationsGenetic TranscriptionGoalsHumanImmediate RecallsImmuneImmune responseImmunityImmunizationImmunologic Deficiency SyndromesInfectionInfectious AgentInflammatoryInflammatory ResponseInflammatory Response PathwayInterferonsInterleukin-10Interleukin-12InvestigationKineticsKnockout MiceLaboratoriesMediatingMemoryMolecularMorbidity - disease rateMusParasitesPathologyPhenotypePopulationProcessProductionProtozoaPublishingReagentRegulationRoleSignal TransductionSourceSystemT cell differentiationT-Cell ReceptorT-LymphocyteT-Lymphocyte SubsetsTh1 CellsTissuesToxoplasma gondiiToxoplasmosisTransgenic MiceTransgenic OrganismsUracilVaccinationVaccinesantimicrobialautocrinecytokinegene inductiongranzyme Bimmunopathologyinsightmicrobialmortalitymouse modelnovelparacrinepathogenpreventprogramspublic health relevanceresponsevaccination strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): A successful cellular immune response to Toxoplasma gondii and many other intracellular pathogens involves a delicate balance between the actions of IL-12, a pro- inflammatory innate cytokine triggered by the parasite and IL-10, a regulatory cytokine produced by adaptive T cells to prevent immunopathology. The overall goal of this proposal is to explore how IL-12 controls the generation and persistence of parasite- reactive CD8 effector and memory cells required for protective immunity and how IL-10 acts in a novel autocrine fashion to avert tissue damage. Using a new mouse model with T-cell lineage specific interference in IL-10 signaling, we have obtained evidence that IL- 10 activation of a T-cell intrinsic anti-inflammatory response is required to prevent morbidity and mortality during T. gondii infection. We will use this transgenic and other knockout mouse models to elucidate the kinetics, regulation and functional consequences of IL-10 responsiveness during the Th1 response to T. gondii and explore a novel mechanism for how IL-10 cell-autonomously restrains Th1 cytokine responses. We have recently described four subpopulations of CD8 cells induced by immunization with the cps-vaccine strain of T. gondii and have published evidence that IL-12 is critically required for the generation of effector CD8 T cells expressing IFN3, granzyme B and KLRG1. In collaboration with Dr. Hidde Ploegh's laboratory at MIT, we have identified the first Kb-restricted CTL epitope from T. gondii and our collaborators have also developed a cloned mouse line bearing monoclonal naove CD8 T cells reactive to this Kb- restricted T. gondii antigen. Using these new mouse and immunological reagents, we will elucidate the cytokine requirements, lineage relationships and functional significance of the heterogenous CD8 T cell subsets induced by T. gondii vaccination and infection. We will critically assess the costs and benefits of IL-12 signaling on the immediate and recall CD8 protective response to re-infection.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1371/journal.ppat.1000815
发表时间:
2010-03-19
期刊:
PLoS pathogens
影响因子:
6.7
作者:
[Wilson DC, Grotenbreg GM, Liu K, Zhao Y, Frickel EM, Gubbels MJ, Ploegh HL, Yap GS]
通讯作者:
Yap GS
DOI:
10.1016/j.chom.2014.05.002
发表时间:
2014-05-14
期刊:
Cell host & microbe
影响因子:
30.3
作者:
[Zhao Y, Yap GS]
通讯作者:
Yap GS
DOI:
10.4049/jimmunol.1601741
发表时间:
2017-01-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Marple A, Wu W, Shah S, Zhao Y, Du P, Gause WC, Yap GS]
通讯作者:
Yap GS
DOI:
10.1038/ni.3375
发表时间:
2016-04
期刊:
Nature immunology
影响因子:
30.5
作者:
[Rivera A, Siracusa MC, Yap GS, Gause WC]
通讯作者:
Gause WC
DOI:
10.7554/elife.09017
发表时间:
2015-08-05
期刊:
eLife
影响因子:
7.7
作者:
[Shah S, Grotenbreg GM, Rivera A, Yap GS]
通讯作者:
Yap GS
GDF-15 as a mediator of immune-regulated sickness response during infection
-
批准号:10598705
-
项目类别:
-
资助金额:$22.8万
-
财政年份:2022
-
负责人:George S. Yap
-
依托单位:
Pathogenic and Protective T cells in Toxoplasmosis
-
批准号:8493980
-
项目类别:
-
资助金额:$36.99万
-
财政年份:2010
-
负责人:George S. Yap
-
依托单位:
Pathogenic and Protective T cells in Toxoplasmosis
-
批准号:8089474
-
项目类别:
-
资助金额:$38.61万
-
财政年份:2010
-
负责人:George S. Yap
-
依托单位:
Pathogenic and Protective T cells in Toxoplasmosis
-
批准号:7992753
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2010
-
负责人:George S. Yap
-
依托单位:
Pathogenic and Protective T cells in Toxoplasmosis
-
批准号:8284445
-
项目类别:
-
资助金额:$38.61万
-
财政年份:2010
-
负责人:George S. Yap
-
依托单位:
Pathogenic and Protective T Cells in Toxoplasmosis
-
批准号:7931239
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2009
-
负责人:George S. Yap
-
依托单位:
Autophagic Defense Against Intracellular Parasites
-
批准号:7582295
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2008
-
负责人:George S. Yap
-
依托单位:
Autophagic Defense Against Intracellular Parasites
-
批准号:7470344
-
项目类别:
-
资助金额:$22.84万
-
财政年份:2008
-
负责人:George S. Yap
-
依托单位:
Generation/Maintenance of Type 1 Immunity to Toxoplasma
-
批准号:6543692
-
项目类别:
-
资助金额:$27.48万
-
财政年份:2002
-
负责人:George S. Yap
-
依托单位:
Regulation of Type1 Immunity to Toxoplasma
-
批准号:7828005
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2002
-
负责人:George S. Yap
-
依托单位:
Generation/Maintenance of Type 1 Immunity to Toxoplasma
-
批准号:7556149
-
项目类别:
-
资助金额:$8.2万
-
财政年份:2002
-
负责人:George S. Yap
-
依托单位:
Generation/Maintenance of Type 1 Immunity to Toxoplasma
-
批准号:6748067
-
项目类别:
-
资助金额:$31.17万
-
财政年份:2002
-
负责人:George S. Yap
-
依托单位:
Generation/Maintenance of Type 1 Immunity to Toxoplasma
-
批准号:6897920
-
项目类别:
-
资助金额:$31.16万
-
财政年份:2002
-
负责人:George S. Yap
-
依托单位:
Regulation of Type1 Immunity to Toxoplasma
-
批准号:7583489
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2002
-
负责人:George S. Yap
-
依托单位:
Generation/Maintenance of Type 1 Immunity to Toxoplasma
-
批准号:7061712
-
项目类别:
-
资助金额:$21.95万
-
财政年份:2002
-
负责人:George S. Yap
-
依托单位:
Generation/Maintenance of Type 1 Immunity to Toxoplasma
-
批准号:6640210
-
项目类别:
-
资助金额:$27.48万
-
财政年份:2002
-
负责人:George S. Yap
-
依托单位:
海外基金